XML 56 R42.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS DEFICIENCY (Details 2)
 9 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
STOCKHOLDERS DEFICIENCY  
Number of Options Outstanding, Beginning | shares 2,263,440
Number of Options Expired | shares (14,338)
Number of Options Outstanding, Ending | shares 2,249,102
Number of Options Exercisable | shares 937,894
Number of Options Expected to vest | shares 1,311,208
Weighted Average Exercise Price Outstanding, Beginning $ 6.11
Weighted Average Exercise Price Granted 0
Weighted Average Exercise Price Forfeited 0
Weighted Average Exercise Price Exercised 0
Weighted Average Exercise Price Expired 4.50
Weighted Average Exercise Price Outstanding, Ending 6.12
Weighted Average Exercise Price Exercisable 10.77
Weighted Average Exercise Price Options Expected to vest $ 2.80
Weighted Average Remaining Term in Years Options outstanding at beginning of year 8 years 2 months 12 days
Weighted Average Remaining Term in Years Options outstanding at end of year 7 years 6 months
Weighted Average Remaining Term in Years Options exercisable at end of year 5 years 10 months 24 days
Weighted Average Remaining Term in Years Options Expected to vest 8 years 7 months 6 days
Aggregate Intrinsic Value Options Expected to vest | $ $ 0
Aggregate Intrinsic Value Options Expected to outstanding | $ 0
Aggregate Intrinsic Value Options Exercisable | $ $ 0